What is the primary purpose of this 8-K filing?

The primary purpose of this 8-K filing is to provide public notice that senior management of UnitedHealth Group will be engaging in investor and analyst meetings, and to reaffirm the company's previously announced increased financial expectations for 2006. This ensures compliance with Regulation FD by broadly disseminating this information.

When are these investor meetings scheduled to take place?

The meetings are scheduled to occur in the latter half of February 2006 and the first half of March 2006.

What key financial information will be discussed?

Management will reaffirm the company's recently increased 2006 financial expectations. While specific figures are not detailed in this 8-K, the reaffirmation suggests continued confidence in the company's financial performance for the year.

What should investors be aware of regarding the company's future outlook statements?

Investors should be aware that any forward-looking statements made during these meetings, or in this filing, are subject to risks and uncertainties. The company explicitly states that actual results could differ materially from management's expectations due to various factors, and advises investors to consult UNH's other SEC filings for a comprehensive list of these risks.

UNH 8-K: Regulation FD — Feb 10, 2006

Summary

UnitedHealth Group Inc. (UNH) has filed an 8-K report on February 10, 2006, to inform investors about upcoming meetings with analysts and investors. During these sessions, scheduled for late February and early March 2006, senior management, including the CEO and President, will discuss the company's strategy, operations, and future outlook. A key takeaway for investors is the reaffirmation of previously announced increased 2006 financial expectations. The filing also includes a standard cautionary statement regarding forward-looking statements, reminding investors that actual results could differ materially from management's projections due to various risks and uncertainties inherent in the healthcare industry and the company's operations. Investors are encouraged to consult UNH's other SEC filings for a comprehensive understanding of these risks.

Key Highlights

1Senior management of UnitedHealth Group, including CEO William W. McGuire, M.D., will meet with investors and analysts in late February and early March 2006.
2Discussions will cover the company's strategy, tactics, and future outlook.
3Management will reaffirm the company's recently increased 2006 financial expectations.
4The filing serves as a Regulation FD disclosure, ensuring broad dissemination of material information.
5A cautionary statement highlights that actual results may differ materially from forward-looking statements.
6Investors are advised to review other SEC filings for detailed information on risks and uncertainties.

UNITEDHEALTH GROUP INC 8-K Report, Regulation FD Disclosure (Feb 10, 2006)

Summary

Key Highlights

Frequently Asked Questions